NCT04288830

Brief Summary

The standard of care for PTSD involves both psychotherapy and pharmacotherapy, but treatment resistance is common. The discovery of effective complementary treatment approaches would have major implications for patients with PTSD. Mindfulness meditation and related practices have been studied intensively in recent years for a variety of psychiatric illnesses, including depression, generalized anxiety disorder, and PTSD. Studies in PTSD suggest that mindful meditation holds promise. For example, mindfulness-based stress reduction (MBSR) has shown effectiveness for reducing symptom severity and improving mental-health related quality of life in combat-exposed veterans and child survivors of sexual abuse. Mechanistically, mindfulness meditation appears to counteract the types of functional changes that have been identified in the brains of patients with PTSD. In particular, while PTSD symptoms are associated with decreased activation of the prefrontal cortex (PFC) and increased amygdala activity, mindfulness meditation is associated with increased PFC activation and decreased amygdala activation. Other physiological effects of mindfulness meditation in patients with PTSD are not fully defined. However, available data suggest that it leads to a normalization of vagal tone and plasma cortisol levels, which are known to be abnormal in patients with chronic PTSD. Research utilizing validated and standardized pre- and post- PTSD outcome measures, in addition to pre- and post- physiologic variables such a vagal tone, plasma cortisol and catecholamine levels, may better the understandings of physiological effects of mindfulness medication.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
63

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 26, 2020

Completed
2 days until next milestone

First Posted

Study publicly available on registry

February 28, 2020

Completed
1.6 years until next milestone

Study Start

First participant enrolled

October 15, 2021

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 27, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 27, 2022

Completed
Last Updated

April 11, 2023

Status Verified

January 1, 2023

Enrollment Period

10 months

First QC Date

February 26, 2020

Last Update Submit

April 10, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in PCL-5 Score

    Score on the PTSD Symptom Checklist for DSM-5. The PTSD Checklist for DSM-5 (PCL-5) is a 20-item self-report measure that assesses the presence and severity of PTSD symptoms. Items on the PCL-5 correspond with DSM-5 criteria for PTSD. The PCL-5 can be used to quantify and monitor symptoms over time, to screen individuals for PTSD, and to assist in making a provisional or temporary diagnosis of PTSD.

    Assessed on Day 1, Day 56, Day 112, and Day 168

Secondary Outcomes (7)

  • Change in BPI score

    Assessed on Day 1, Day 56, Day 112, and Day 168

  • Change in BDI score

    Assessed on Day 1, Day 56, Day 112, and Day 168

  • Change in PSQI score

    Assessed on Day 1, Day 56, Day 112, and Day 168

  • Change in COPM score

    Assessed on Day 1, Day 56, Day 112, and Day 168

  • Change in Salivary Cortisol

    Assessed on Day 1, Day 56, Day 112, and Day 168

  • +2 more secondary outcomes

Study Arms (2)

TCMMMRT First

EXPERIMENTAL

Participants will perform an instructor-led mind-body exercise regimen 1 day per week during this arm of the study for a total of 8 weeks. Home practice will be logged. At the completion of the TCMMMRT Condition, participants will perform an instructor-led low impact aerobic exercise regimen 1 day per week for a total of 8 weeks. Home exercise will be logged.

Behavioral: Tai Chi Moving Mindfulness Meditation and Resilience TrainingBehavioral: Aerobic Exercise

Aerobic Exercise First

ACTIVE COMPARATOR

Participants will perform an instructor-led low impact aerobic exercise regimen 1 day per week during this arm of the study for a total of 8 weeks. Home exercise will be logged. At the completion of the aerobic exercise condition, participants will perform an instructor-led mind-body exercise regimen 1 day per week for a total of 8 weeks. Home practice will be logged.

Behavioral: Tai Chi Moving Mindfulness Meditation and Resilience TrainingBehavioral: Aerobic Exercise

Interventions

Low-impact mind-body exercise adapted from traditional tai chi.

Aerobic Exercise FirstTCMMMRT First

Low-impact aerobic exercise, led by instructor

Aerobic Exercise FirstTCMMMRT First

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • working in law enforcement
  • between the ages of 18 and 65
  • Both men and women
  • Must meet criteria for PTSD as determined by the PCL-5 instrument on the day of initial assessment.

You may not qualify if:

  • taking sedative or stimulant drugs daily
  • physical illness, injury, or disability preventing safe execution of low impact aerobic exercise

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Johns Hopkins Bayview Medical Center

Baltimore, Maryland, 21224, United States

Location

MeSH Terms

Conditions

Stress Disorders, Post-Traumatic

Interventions

Exercise

Condition Hierarchy (Ancestors)

Stress Disorders, TraumaticTrauma and Stressor Related DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Una McCann

    Johns Hopkins University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 26, 2020

First Posted

February 28, 2020

Study Start

October 15, 2021

Primary Completion

July 27, 2022

Study Completion

July 27, 2022

Last Updated

April 11, 2023

Record last verified: 2023-01

Data Sharing

IPD Sharing
Will not share

Locations